Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms.

Tencho Tenev1, Anna Zachariou, Rebecca Wilson

  • 1The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, Fulham Road, London SW3 6JB, UK.

Nature Cell Biology
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updating national diagnostic reference levels for adult cardiac interventional procedures in Switzerland.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Impact of obesity on 1-year major adverse cardiac events after primary PCI for STEMI.

International journal of cardiology·2026
Same author

The Obesity Paradox in Major Adverse Cardiovascular Events After PCI for Acute Coronary Syndrome: A Narrative Review.

Journal of cardiovascular development and disease·2026
Same author

Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.

Circulation·2026
Same author

Murray law-based quantitative flow ratio for functional assessment of coronary lesions: a systematic review and meta-analysis.

The international journal of cardiovascular imaging·2026
Same author

Radial Wall Strain and the Stepwise Integration of Physiology and Vulnerability in Revascularization Decision Making.

JACC. Asia·2026
Same journal

Learning from stem cell-based embryo models.

Nature cell biology·2026
Same journal

Why the temporal dimension matters in cellular signalling.

Nature cell biology·2026
Same journal

Transcription factor condensates as storage.

Nature cell biology·2026
Same journal

Author Correction: Spatial regulation of VEGF receptor endocytosis in angiogenesis.

Nature cell biology·2026
Same journal

Mitochondria-endoplasmic reticulum contact sites as hubs where mitochondria acquire iron.

Nature cell biology·2026
Same journal

Cis and trans regulatory mechanisms of extrachromosomal DNA segregation.

Nature cell biology·2026
See all related articles

Inhibitors of apoptosis (IAPs) regulate cell death differently. While some directly inhibit caspases, others like DIAP1 use an IAP-binding motif (IBM) for regulation, keeping caspases active.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Apoptosis Research

Background:

  • Inhibitor of Apoptosis (IAP) proteins are crucial regulators of programmed cell death (apoptosis).
  • Existing models propose IAPs suppress apoptosis by directly inhibiting caspases, key executioners of cell death.
  • This function is thought to involve IAPs binding to the active sites of caspases.

Purpose of the Study:

  • To investigate the functional diversity and distinct mechanisms of IAP proteins in caspase regulation.
  • To challenge the universal model of IAPs as direct caspase enzyme inhibitors.
  • To elucidate the role of the IAP-binding motif (IBM) in IAP-caspase interactions.

Main Methods:

  • Comparative analysis of XIAP and Drosophila IAP1 (DIAP1) in caspase regulation.

Related Experiment Videos

  • Biochemical assays to assess caspase activity upon IAP binding.
  • Investigation of IAP-binding motif (IBM) dependency in mammalian c-IAP1 interactions with caspase-7.
  • In vivo studies using mutant caspases to assess apoptotic potency.

    • Main Results:

    • IAPs are functionally non-equivalent, employing distinct mechanisms to regulate effector caspases.
    • XIAP directly binds to and inhibits effector caspases via their active sites.
    • DIAP1 regulation of caspases depends on an IAP-binding motif (IBM) and leaves caspases catalytically active.
    • Mammalian c-IAP1 interacts with caspase-7 in an IBM-dependent, active site-independent manner, similar to DIAP1.
    • IBM-mutant caspases exhibit enhanced apoptotic potency in vivo, highlighting the significance of IBM-mediated regulation.

    Conclusions:

    • The model of IAPs solely acting as direct caspase inhibitors is incomplete.
    • Distinct IAP regulatory mechanisms exist, including IBM-dependent interactions that maintain caspase activity.
    • The IBM is a critical element in the regulation of effector caspases across species.
    • Understanding these diverse mechanisms is vital for comprehending apoptosis control and developing therapeutic strategies.